We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
(-0.91%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$92.9M |
| 2 |
Amazon
AMZN
|
+$62.6M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$46.3M |
| 4 |
VMEO
Vimeo
VMEO
|
+$33.1M |
| 5 |
UnitedHealth
UNH
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$49.9M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$43.5M |
| 3 |
Humana
HUM
|
+$36.6M |
| 4 |
Vipshop
VIPS
|
+$35.6M |
| 5 |
Brookfield
BN
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.6% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 10.46% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
PDS Biotechnology
PDSB
$38.1M
| $2.92M | 0.01% |
195,819
+22,888
| +13% | +$285K |
|
277
General Motors
GM
$74.7B
| $2.91M | 0.01% |
55,217
| – | – |
|
278
Esquire Financial Holdings
ESQ
$1.04B
| $2.9M | 0.01% |
101,100
+20,000
| +25% | +$510K |
|
279
Starbucks
SBUX
$118B
| $2.9M | 0.01% |
26,248
-103
| -0.4% | -$12.1K |
|
280
Alliance Resource Partners
ARLP
$3.18B
| $2.85M | 0.01% |
262,500
-117,500
| -31% | -$979K |
|
281
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
| $2.84M | 0.01% |
28,883
-1,125
| -4% | -$114K |
|
282
AllianceBernstein
AB
$3.47B
| $2.83M | 0.01% |
57,000
| – | – |
|
|
QIPT
283
DELISTED
Quipt Home Medical
QIPT
| $2.81M | 0.01% |
446,250
+160,250
| +56% | +$961K |
|
284
Devon Energy
DVN
$51.9B
| $2.78M | 0.01% |
78,227
| – | – |
|
285
Unitil
UTL
$1,000M
| $2.77M | 0.01% |
64,789
| – | – |
|
286
Repligen
RGEN
$7.44B
| $2.75M | 0.01% |
9,515
| – | – |
|
287
Blackstone
BX
$104B
| $2.74M | 0.01% |
23,527
-357
| -1% | -$41.4K |
|
288
iShares S&P 500 Growth ETF
IVW
$72.5B
| $2.72M | 0.01% |
36,861
+36,816
| +81,813% | +$2.81M |
|
289
Chipotle Mexican Grill
CMG
$40.8B
| $2.71M | 0.01% |
74,550
| – | – |
|
290
SBA Communications
SBAC
$18.4B
| $2.58M | 0.01% |
7,815
+645
| +9% | +$223K |
|
|
PMBC
291
DELISTED
Pacific Mercantile Bancorp
PMBC
| $2.57M | 0.01% |
279,278
-68,922
| -20% | -$597K |
|
292
Liberty Media Series C
FWONK
$24.3B
| $2.55M | 0.01% |
51,285
-60,680
| -54% | -$2.87M |
|
293
Yum China
YUMC
$14.9B
| $2.54M | 0.01% |
43,637
+322
| +0.7% | +$19.8K |
|
294
Teva Pharmaceuticals
TEVA
$35.9B
| $2.53M | 0.01% |
259,766
+9,972
| +4% | +$93.4K |
|
295
Zimmer Biomet
ZBH
$17.7B
| $2.52M | 0.01% |
17,701
-277
| -2% | -$40.7K |
|
|
BNY
296
Bank of New York Mellon
BNY
$108B
| $2.51M | 0.01% |
48,445
-13,269
| -22% | -$690K |
|
|
ARCH
297
DELISTED
Arch Resources, Inc.
ARCH
| $2.5M | 0.01% |
27,000
-8,000
| -23% | -$562K |
|
298
Liberty Global Class C
LBTYK
$3.25B
| $2.49M | 0.01% |
84,687
-934
| -1% | -$25.9K |
|
299
DuPont de Nemours
DD
$18.6B
| $2.49M | 0.01% |
29,204
+1,390
| +5% | +$129K |
|
300
Allstate
ALL
$66.9B
| $2.45M | 0.01% |
19,277
-242
| -1% | -$32K |
|
Similar funds
SAM
First Manhattan's Q3 2021 Portfolio in Review
As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
- First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
- First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
- First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
- First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
- First Manhattan opened 132 new positions and closed 93 in Q3 2021.
- First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.
Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.